Stenocare AS (FRA:S7C) Long-Term Debt: €0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:S7C Stenocare AS FRA:S7C
40 GF Score
Price €0.13
GF Value €0.29
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Stenocare AS Long-Term Debt?

Stenocare AS FRA:S7C 40 Long-Term Debt is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:S7C with a GF Score™ of 40/100 and a GF Value™ of €0.29 (Possible Value Trap). The stock has 4 warning signs investors should review.

Stenocare AS's Long-Term Debt for the quarter that ended in Mar. 2026 was €0.00 Mil.

Stenocare AS's quarterly Long-Term Debt declined from Sep. 2025 (€0.07 Mil) to Dec. 2025 (€0.00 Mil) but then stayed the same from Dec. 2025 (€0.00 Mil) to Mar. 2026 (€0.00 Mil).

Stenocare AS's annual Long-Term Debt increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.27 Mil) but then declined from Dec. 2024 (€0.27 Mil) to Dec. 2025 (€0.00 Mil).

Stenocare AS  (FRA:S7C) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Stenocare AS Long-Term Debt Related Terms

Stenocare AS Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Stenocare AS's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stenocare AS Long-Term Debt Chart

Stenocare AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 0.00 0.48 0.00 0.27 0.00

Stenocare AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.14 0.07 0.00 0.00
FRA:S7C
40GF Score
Stenocare AS FRA:S7C
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €0.00 Mil mean?
Stenocare AS (FRA:S7C) has a Long-Term Debt of €0.00 Mil as of Mar. 2026.
Is Stenocare AS's Long-Term Debt too high?
Stenocare AS's current Long-Term Debt is €0.00 Mil. Overall, Stenocare AS has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Stenocare AS's Long-Term Debt compare to ZTS and UTHR?
Stenocare AS's Long-Term Debt of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Stenocare AS's current Long-Term Debt is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stenocare AS stock overvalued right now?
Based on GuruFocus' analysis, Stenocare AS (FRA:S7C) is currently considered Possible Value Trap. The stock's GF Value™ is €0.29, compared to a current price of €0.13 — trading 56.2% below its estimated fair value. The current Long-Term Debt is €0.00 Mil. Stenocare AS's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Stenocare AS (FRA:S7C), the current Long-Term Debt is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stenocare AS (FRA:S7C) Overvalued in 2026?

Based on GuruFocus' analysis, Stenocare AS stock appears to be undervalued. The current stock price of €0.13 is trading 56.2% below its estimated GF Value™ of €0.29. GuruFocus considers Stenocare AS to be Possible Value Trap.

Key valuation signals for FRA:S7C:

  • Long-Term Debt: €0.00 Mil
  • GF Value™: €0.29 vs. price of €0.13 (56.2% below fair value)
  • GF Score™: 40/100 with 4 warning signs

No single metric tells the full story. See the FRA:S7C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stenocare AS Business Description

Other Exchanges STENO:Denmark
Address Lejrvej 9, Vaerlose, DNK, 93500
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway.
40GF Score

Get the complete analysis for FRA:S7C

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price
€0.29
GF Value